1-1 of 1
Dean Y. Maeda
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 1 Results of the First-in-Class CXCR1/2 Inhibitor SX-682 in Patients with Hypomethylating Agent Failure Myelodysplastic Syndromes

David A. Sallman, Amy E. DeZern, Arlene A. Gayle, Stuart J. Kahn, Eric Padron, Jeffrey E. Lancet, Andrew Kuykendall, Kendra Sweet, Onyee Chan, Dean Y. Maeda, Aaron D. Schuler, John A. Zebala, Rami S. Komrokji
Journal: Blood
Blood (2022) 140 (Supplement 1): 2070–2072.
https://doi.org/10.1182/blood-2022-159774
Published: 2022